Geoffrey Kim, M.D. joined BeiGene in 2019 as Vice President, Applied Innovation, leading the creation and incubation of technological solutions to increase patient access to clinical trials and novel therapeutics.

Prior to his appointment at BeiGene, Dr. Kim served in various senior roles at AstraZeneca, including Vice President, Oncology Regulatory Science and Strategy, as well as Head of Strategic Combinations in the immuno-oncology franchise. Previously, Dr. Kim oversaw the evaluation and regulation of oncology drug products for breast, genitourinary, and gynecologic cancers as a division director in the Office of Hematology Oncology Products at the U.S. Food and Drug Administration. He additionally worked on numerous cross-center initiatives such as companion diagnostics, dose-finding optimization strategies, and the Oncology Center of Excellence.

Dr. Kim is board certified in medical oncology and internal medicine and completed his medical oncology fellowship at the National Cancer Institute and his residency in internal medicine at the Montefiore Medical Center. He received his medical degree from New York Medical College and a B.S. in 1999 from the University of California, Los Angeles.